Evaluation of Irritancy/Allergic Sensitivity to Natural Personal-care Products by Patch Tests

Sponsor
Mother's Choice Ltd (Industry)
Overall Status
Unknown status
CT.gov ID
NCT01816542
Collaborator
(none)
100
1
1
3
33.1

Study Details

Study Description

Brief Summary

The purpose of the study is to determine if any of Mother's Choice' all-natural personal-care products cause either irritation or allergic reaction when applied to both normal or sensitive skin.

Each product will be tested on the skin using patch tests.

Condition or Disease Intervention/Treatment Phase
  • Other: patch tests on healthy skin
N/A

Detailed Description

Volunteers will be seen on Day #0 and the study purpose will be explained. Each volunteer will be interviewed to determine if he/she has any exclusion criteria.

If there is no contraindication, and agreement is achieved,consent forms will be signed.

Volunteers will be examined by a lactic acid test to determine if he/she has normal or sensitive skin. In this test, a Finn's cell (plastic cell, size 1*1 cm) with lactic acid (50 microliter, 10%w/v) will be placed on the volunteer's cheek for ten minutes. The volunteer will be defined as "sensitive" or "normal" according to the degree of discomfort they report.

Patch-tests will be performed in the standard method. The materials to be tested will be placed in Finn's cells and attached to the participants healthy skin's back by a plaster (Micropore).The chambers will be left on the skin for 48 hours. The test will be read by a specialist one hour after chambers' removal and 48 hours afterwards. Any erythema,edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response, and will be evaluated by clinical tools as being of the irritant or the allergic type. in case of uncertainty we may use a confocal microscope for in vivo diagnosis.

Ingredients: appropriate concentrations and solvents of the test materials will be prepared according to accepted standards (refer to: Anton C. De Groot: Patch Testing, 3ed Edition, Wapserveen, The Netherlands, 2009).Leave on products will be tested 'as is'. Rinse off products will be diluted to 5% and 0.5%.

If the skin stays normal after the patch removal, it means that contact with the material did not cause allergy or irritation.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Dermatologically Tested - Patch Tests - to Assess the Irritancy/Allergic Sensitivity of the Natural Personal-care Products Developed by "Mother's Choice".
Study Start Date :
Jun 1, 2013
Anticipated Primary Completion Date :
Aug 1, 2013
Anticipated Study Completion Date :
Sep 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Other: patch tests on healthy skin

Other: patch tests on healthy skin
Patches will be placed on healthy skin.

Outcome Measures

Primary Outcome Measures

  1. Number of participants with positive reactions, number of positive reactions. [One week]

    Erythema, edema, blisters, pustules or erosions on the skin in the patch area will be considered a positive response. If the skin is normal after the patch removal, it means that contact with the material do not cause allergy or irritation.

Secondary Outcome Measures

  1. Number of irritant versus allergic reactions, as determined by confocal microscopy. [On the spot]

    In case of a positive reaction, it will be examined by confocal microscopy, by a specialist, to determine whether the reaction is irritant or allergic in nature.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Healthy adults
Exclusion Criteria:
  • Pregnant subjects

  • Subjects with an allergy or a skin disease which interferes with the proper results of the tests.

  • Subjects who are taking medications which can interfere with the proper results of the tests. For example: systemic corticosteroids, topical steroids applied to the test area.

  • Subjects with sun or phototherapy induced tanning at the test area.

  • Subject who had been participating in allergy tests within eight weeks prior to the present tests.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Dermatology, Hadassah University Hospital Jerusalem Israel 91120

Sponsors and Collaborators

  • Mother's Choice Ltd

Investigators

  • Principal Investigator: Arieh Ingber, MD Prof., Hadassah University Hospital, Department of Dermatology
  • Principal Investigator: Liran Horev, MD, Hadassah University Hospital, Department of Dermatology

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mother's Choice Ltd
ClinicalTrials.gov Identifier:
NCT01816542
Other Study ID Numbers:
  • MC-2013-PT-BA
First Posted:
Mar 22, 2013
Last Update Posted:
Mar 22, 2013
Last Verified:
Mar 1, 2013
Keywords provided by Mother's Choice Ltd
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2013